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Abstract 
Background and Objectives Pathological alterations of glutamatergic systems were 
observed in neurodegenerative and psychiatric disorders. There is some evidence that this 
system may be involved in the genetic vulnerability to suicide. The aim of the present study 
was to analyze possible relationship between the GRIN2B polymorphism and suicidal 
behavior. We hypothesized that this genetic factor may be associated with suicide attempts in 
alcohol-dependent patients and with death by suicide. 
Methods To analyze the relationship between GRIN2B and suicide attempts, the selected 
rs2268115 polymorphism was genotyped in a sample of 345 alcohol-dependent individuals 
stratified by the history of suicide attempts. The second part of the study concerning suicide 
was based on a sample of 510 suicide victims and 450 controls. 
Results The frequency of rs2268115 G allele among alcohol-dependent patients with the 
history of suicide attempts was significantly higher than among non-suicidal alcohol-
dependent individuals (OR=1.45, p=0.033). This association was more significant when 
analyzing alcohol-dependent patients only without co-occurring drug dependence (OR=1.62, 
p=0.021). The analyzed GRIN2B polymorphism was associated with a twofold increase in 
odds of a suicide attempt (OR=2.01, p=0.004). No relationships between rs2268115 and death 
by suicide were identified. 
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Discussion and Conclusions Our results suggest that glutamatergic system influence 
susceptibility to suicide attempts in alcohol-dependent individuals. Suicidal behavior and 
alcohol dependence may share a common etiology related to the glutamatergic system. 
Scientific Significance The major contribution of the present study is a novel finding of the 
possible association between GRIN2B rs2268115 polymorphism and suicide attempts in 
alcohol-dependent individuals. 
Background and Objectives 
Suicide is a complex behavior with diverse risk factors, which include coexisting 
psychiatric disorders, addictions, personality traits, somatic comorbidity and socio-
demographics, and demonstrated genetic susceptibility. Alcohol, opioid and other drugs 
dependence is consequently considered as an important predictor of suicidal behavior. 
However  there are a lot of inconsistency when analyzing how this association varies across 
different types of drugs 1. Recently it was reported that risk of suicide attempts is strongest it 
those with alcohol dependence. Other drug users including: opioid, cocaine, stimulants, 
hallucinogens were less likely to attempt suicide. The lowest likehood of suicidal behavior 
was linked with cannabis use disorder. This study was performed on a population diagnosed 
with personality disorders or other psychiatric disorders 2. 
The majority of previous research on the genetic vulnerability to suicidal behavior 
focused on the serotonergic system, the noradrenergic system and the hypothalamic-pituitary-
adrenal axis 3. The results of the previous studies are often inconsistent and require further 
clarification. More research is needed to identify, evaluate and understand the genetic 
background of suicide behavior.  
It seems that the glutamatergic system, which plays an important role in synaptic 
plasticity and moderates learning, cognition and memory functions 4, should be analyzed as 
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another neurosystem influencing vulnerability to suicidal behavior.  Glutamate is the major 
excitatory neurotransmitter in the brain 5, which operates through metabotropic and ionotropic 
receptors. The ionotropic receptors are further divided into N-methyl-d-aspartate (NMDA) 
receptors and non-NMDA receptors 6.  Dysfunctions in the glutamatergic system, especially 
in NMDA receptors are linked with neurodegenerative disorders, in particular with 
Alzheimer's disease 7, Parkinson’s disease 8, Huntington's disease 9 and epilepsy 10. There is 
also growing evidence that the glutamatergic system influences the susceptibility to 
depression 4.  NMDA receptor is a binding and modulation site for antidepressants 11. 
Disrupted function of NMDA receptors was also reported as the possible etiology of 
schizophrenia 12, anxiety disorders 13, neuroticism 14, antisocial personality disorder 14 and 
alcohol dependence 15. 
Pathological alterations of the glutamatergic systems have also been observed in 
suicide victims 16. Abnormalities in the gene expression levels of the NMDA receptors had 
been discovered in patients with depressive disorder who committed suicide 17.  
Recently, Sokolowski et al. 18 performed a family based study with offspring recruited 
from the emergency department because of severe suicide attempts. They reported the 
association between the genetic variants in the subset of NMDA receptor (GRIN2B) and 
suicide attempts. This association was stronger for participants characterized by past year 
alcohol or drug use disorders, but not by alcohol or drug use at the time of suicide attempt. To 
the best of our knowledge this association has not been investigated in other populations. 
The purpose of the present study was to further investigate the association between the 
GRIN2B rs2268115 polymorphism and suicidal behavior. We investigated a sample of 
alcohol-dependent individuals with history of suicide attempt to verify our hypotheses that 
GRIN2B variants might be involved in the vulnerability to suicide attempt, particularly in 
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alcohol or drug-dependent individuals. Additionally, we aimed to analyze the possible 
relationship between the GRIN2B rs2268115 polymorphism and death by suicide.  
Methods 
The first part of the study concerning suicide attempts was based on a sample of 345 
alcohol-dependent individuals recruited at the abstinence-based, drug-free treatment programs 
and in the methadone maintenance treatment clinic in Warsaw, Poland. This cohort consisted 
of 225 alcohol-dependent patients (with no comorbid drug use disorders) and 120 alcohol and 
opioid-dependent subjects (with comorbid stimulant use disorder - 74 % and cannabis use 
disorder - 86 %) . The diagnosis of alcohol or drug dependence was established after 
psychiatric examination. In addition, the MINI International Neuropsychiatric Interview  was 
used to diagnose addictions and co-occurring psychiatric disorders.  
Lifetime history of suicide attempts as the key dependent variable was evaluated with 
Suicidality Module of the MINI. The methods of suicide attempts were classified as violent 
methods: hanging, shooting, jumping from heights, cutting, drowning, other methods and 
non-violent suicide method: poisoning (as listed in chapter X by the ICD-10 classification). 
Additionally, patients were asked to complete questionnaire that included questions about 
previously reported risk factors for suicide attempts including: demographics, somatic and 
psychiatric comorbidity, and economic status. To assess the severity of alcohol dependence 
the Michigan Alcohol Screening Test (MAST) was used. Depressive symptoms were 
evaluated with the Beck Depression Inventory (BDI). The Barratt Impulsiveness Scale (BIS-
11) was used to assess impulsivity. Social support was examined using the Medical Outcomes 
Study Social Support Survey (MOSSSS). The characteristics of alcohol-dependent 
participants are presented in table 1. 
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To be eligible for the study, participants had to be over 18 years old. The exclusion 
criteria for the participation were inability to understand the purpose of the study and to give 
informed consent. 
The second part of the study concerning death by suicide was based on a sample of 
510 suicide victims autopsied from 2005 to 2013 in the Department of Forensic Medicine at 
the Medical University of Warsaw, Poland. Suicide as a cause of death was confirmed during 
post-mortem examinations and finally verified in prosecutor’s inquiries. Characteristics of 
suicide victims, which included basic demographic data, methods of suicide, and blood 
alcohol concentration (BAC) at the time of death, were derived from post-mortem medical 
and forensic examination protocols. The majority of cases were males (n=440, 86.3%). The 
mean age at death was 42.8 ± 16.3 years. In this sample, 44.7 % (n=228) of suicide victims 
had BAC>0.2‰. Those cases were classified as suicides under the influence of alcohol at the 
time of death, which is in accordance with Polish law. The average BAC in this group was 1.7 
± 0.9‰.  Over ninety-seven percent of the sample (n=496, 97.3%) committed violent suicide. 
Hanging was the most frequent suicide method (n=416, 81.6%). These demographic variables 
of suicide decedents were comparable to Polish national data on suicide 19. 
The comparison group consisted of 450 individuals tested for disputed paternity at the 
Department of Forensic Medicine as described previously 20. The male frequency was 52.9% 
(n=238), mean age was 36.9 ± 10.0 years. This cohort was previously reported as 
representative for population of Poland 21. 
All participants were Polish Caucasians. Since, according to National Census of 
Population and Housing, Poland was nearly ethnically homogeneous (97.7 % of the 
population declared Polish ethnonationality), race composition was not additionally analyzed. 
Alcohol-dependent patients and individuals tested for disputed paternity gave written consent 
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for participation in the study and for the anonymous use of their DNA for research. The study 
was approved by the Bioethics Committee of the Medical University of Warsaw.  
Genotyping 
DNA was isolated from blood or saliva samples using standard salting procedures. 
The selected polymorphism rs2268115 in GRIN2B was genotyped by the Real-Time PCR 
(polymerase chain reaction) using Open Array Technology. Pre-designed primers were 
obtained from Applied Biosystems (Pre-designed TaqMan SNP Genotyping Assays, 7500 
Real Time PCR System, Applied Biosystems, Assay ID C___2682138_1) on an ABI PRISM 
9700 platform (Applied Biosystems). The results were analyzed using 7500 System SDS 
Software (Applied Biosystems). 
Among alcohol-dependent patients the genotyping success cell rate was 98.51% (340 
samples + 5 undetermined samples), among suicide victims – 98.6% (503 samples + 7 
undetermined samples), among comparison subjects – 99.8% (449 samples + 1 undetermined 
sample). The study had the power of 0.8 to detect at α = 0.05 an allelic association conferring 
OR~1.62. 
Statistical analysis 
Genotyping results were tested for Hardy-Weinberg Equilibrium using the Web-
Assotest program (http://www.ekstroem.com/assotest/assotest.html). This program was also 
applied for analyzing genotype distribution in cases and controls assuming dominant, co-
dominant and recessive model of inheritance. P value for model fit (Pfit) determined  the most 
likely model of inheritance .   
Comparison of the genotype and allele distribution after adjusting for age and gender was 
performed by multiple logistic regression analysis using SPSS software, v. 20.0. Continuous 
variables were checked for normal distribution by the Kolmogorov-Smirnov test. Differences 
between analyzed groups with and without a history of suicide attempts were estimated using 
Au
tho
r M
an
us
cri
pt
This article is protected by copyright. All rights reserved 8 
 
chi-square tests for categorical variables and the Mann-Whitney U tests for continuous non-
parametric variables. Logistic regression was applied to examine the adjusted associations 
between analyzed characteristics and suicide attempts.  
Results 
The genotype distribution in the analyzed polymorphism rs2268115 in GRIN2B was in 
Hardy-Weinberg equilibrium among suicide victims, controls and alcohol-dependent 
individuals (table 2).  
The frequency of G allele among alcohol-dependent individuals with the history of 
suicide attempts (50.6%) was higher than among non-suicidal alcohol-dependent patients 
(41.3%, OR=1.45, CI: 1.03; 2.06, p=0.033, table 2). Analysis of genotype distribution in 
rs2268115 also revealed the association between this polymorphism and suicide attempts in 
alcohol-dependent patients. Co-dominant model of inheritance had the best fit (OR=1.43, 
CI:1.02; 2.01, p=0.038).  
Those relationships were stronger when analyzing only alcohol-dependent patients 
without co-occurring drug dependence: both in the allelic comparison (OR=1.62, CI:1.07; 
2.46, p=0.021) and in the analysis of models of inheritance (co-dominant model: OR=1.57, 
CI:1.05; 2.34, p=0.027).  
No association between rs2268115 and suicide attempt was found when analyzing 
only alcohol-dependent patients with co-occurring opioid dependence. To understand those 
findings, the possible differences between the two groups of alcohol-dependent patients with 
or without co-occurring opioid dependence were examined. We found that alcohol-dependent 
only individuals significantly differed from subjects with co-occurring opioid dependence: 
they were older (p<0.001, table 1), had higher scores in MAST (p<0.001), were more 
impulsive according to BIS-11 (p<0.001), and had lower social support as measured by 
MOSSSS (p<0.001).  
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Phenotype-oriented analyses performed in the whole sample of alcohol-dependent 
individuals revealed correlations between suicide attempts and worse social support (p<0.001, 
table 3), impulsivity (p<0.001) as well as severe symptoms of depression (p<0.001). The 
association between rs2268115 and suicide attempts in alcohol-dependent sample remained 
significant after controlling for the above mentioned variables included in the logistic 
regression model (OR=1.67, CI:1.14; 2.46, p=0.008; table 4).  
Given the stronger association between rs2268115 and suicide attempts in alcohol-
dependent patients without co-occurring drug dependence, phenotype-oriented analyses were 
performed within this group to explore this relationship further. Patients who tried to commit 
suicide in this group were older (p=0.008, table 3), more impulsive (p<0.001), had worse 
social support (p<0.001), were more likely to suffer from severe depression (p<0.001). To 
analyze risk factors for suicide attempts in alcohol-dependent individuals without co-
occurring drug dependence logistic regression was performed. The analyzed GRIN2B 
polymorphism was associated with a twofold increase in odds of a suicide attempt (OR=2.01, 
CI:1.25; 3.24, p=0.004, table 4).  
No significant differences in either genotype or allele distributions were found 
between suicide victims and comparison group (table 2). Phenotype-oriented analysis 
performed in these groups also did not reveal any associations between analyzed 
characteristics including sex, age, method of suicide or death under the influence of alcohol. 
To exclude the possible association between rs2268115 and alcohol dependence,  the 
comparison between the alcohol-dependent group from the first part of the study and the 
control group from the second part of the study was performed. No association was detected 
(p>0.05). 
Discussion and Conclusions 
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The major finding of the present study is the association between GRIN2B rs2268115 
polymorphism and suicide attempts in alcohol-dependent individuals. This relationship was 
stronger when analyzing alcohol-dependent patients only, without co-occurring opioid 
dependence. The investigated polymorphism was associated with a twofold increase in odds 
of suicide attempt in this population.  
To the best of our knowledge prior work did not examine the association between 
GRIN2B rs2268115 polymorphism and suicide attempts in alcohol-dependent patients. Our 
findings are consistent with previous research 18, which analyzed relationship between 
rs2268115 and suicide attempts in general population. Interestingly, in that study the GRIN2B 
rs2268115 association was stronger in a subgroup with diagnosis of alcohol or drug use 
disorders. Consistently with our work, Sokolowski et al. also reported the minor allele of 
rs2268115 as a risk factor for suicide attempts.  
The glutamatergic dysfunctions were previously reported as involved in 
psychopathology of suicide.  Prior research described the alterations in NMDA receptor 
complex in the frontal cortex in suicide victims 22. The differences in cortical NMDA 
receptors expression were demonstrated in suicide decedents 16. Higher expression levels of 
GRIN2B were detected in patients with major depressive disorder who committed suicide 23. 
Additionally, since NMDA-receptor antagonist ketamine was reported to reduce suicidality in 
depressed patients, this signaling pathway is considered as a potential part of the 
pathophysiology of suicidal behavior 24.  
Given above mentioned results, the second part of our study was aimed to examine the 
hypothesis that the selected GRIN2B polymorphism may be associated with death by suicide. 
However, our results did not confirm this assumption. Previous genome-wide association 
studies (GWAS) regarding suicide attempts or suicides also did not report the associations 
with GRIN2B 25. It seems important to emphasize that, to the best of our knowledge, none of 
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these studies were conducted specifically in alcohol-dependent patients with the history of 
suicide attempts. 
Alterations in the glutamatergic system were described as a possible background not 
only of suicidal behavior 18, but also of alcohol dependence 15,26. Ethanol acts by inhibiting 
neuronal NMDA receptor function. GRIN2B subunit are particularly sensitive to ethanol-
induced inhibition. Chronic ethanol exposure induces an upregulation of various NMDA 
receptor subunits including GRIN2B and leads to changes in genes expression via 
methylation. These neuroadaptive changes are considered to play an important role in 
development of tolerance and alcohol withdrawal symptoms 27. Previous molecular research 
reported association between GRIN2B polymorphisms and alcohol dependence 26,28. The 
results of the present study indicate that GRIN2B may be involved in vulnerability to suicide 
attempts in alcohol-dependent individuals. Increased levels of glutamate have been shown to 
reduce dopaminergic transmission 29. Glutamatergic neurotransmission, in particular within 
the mesolimbic dopamine pathway, plays a crucial role in development of alcohol addiction 
30. We hypothesize that suicidal behavior and alcohol dependence may share a common 
etiology directly related to the glutamatergic system.  
Interestingly, the reported association between rs2268115 and suicide attempts was 
stronger when analyzing alcohol-dependent patients only, without co-occurring drug 
addiction. The comparison between alcohol-dependent patients with and without coexisting 
opioid dependence revealed significant differences. The severity of alcohol dependence and 
impulsivity levels were much higher in those without opioid dependence. Previously, GRIN2B 
polymorphisms were reported to be associated with risky decision-making and impulsivity 31. 
Both the severity of alcohol dependence and impulsivity are well documented risk factors for 
suicide attempts 32.  More research is required to understand relationships between above 
mentioned clinical characteristics and genetic vulnerability to suicidal behavior.  In addition, 
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genetic background of suicide attempts may differ in patients with alcohol dependence and 
those with opioid dependence. Recently, our study demonstrated an association between 
suicide attempts in opioid-dependent patients and DISC1 rs2738888 polymorphism, however, 
no such relationship was found in alcohol-dependent subjects 33.  
The most important risk factor for suicide attempt in alcohol-dependent subjects in the 
present study was severe depression with almost a fivefold increase in odds of a suicide 
attempt. Ketamine, the NMDA receptors antagonist is recently widely discussed as a potential 
rapid-acting antidepressant and antisuicidal drug 34. Alcohol-dependent patients with 
coexisting severe depression and suicidal behaviors might particularly benefit with ketamine 
treatment.  
The interpretation of findings of the present study is difficult because of complexity of 
the phenotype of suicidal behavior and the wide interactions between the glutamatergic 
system and other neurotransmitters involved in pathophysiology of suicide. More research is 
needed to understand the relationships between genetic variants of the glutamatergic system 
and susceptibility to suicidal behavior. Particularly valuable seems research performed in 
large populations with phenotypes described in detail.   
Limitations 
Several limitations of the present study are important to consider. First, the study 
sample was relatively small, but we were able to analyze the possible association between the 
selected GRIN2B polymorphism and suicidal behavior including suicide attempts and 
suicides. In addition, the study had sufficient power to conduct preliminary analyses. 
Moreover, the present study focused only on one genetic alteration in the glutamatergic 
system. However, we selected this polymorphism on intention, because it was previously 
reported to be associated to suicide attempts in general population and we aimed to 
investigate it further.  
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Scientific Significance  
The present findings suggest the possible association between GRIN2B rs2268115 
polymorphism and suicide attempts in alcohol-dependent individuals. We have not confirmed 
the hypothesis that the selected GRIN2B polymorphism may be involved in genetic 
background of death by suicide. Alcohol-dependent patient with severe depressive symptoms 
and history of suicidal behavior may potentially benefit with treatment approach using agents 
targeting the glutamatergic system.  
Declaration of Interest  
The authors report no conflicts of interest. The authors alone are responsible for the 
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Table 1. Characteristics of alcohol-dependent participants. 
 
Variables All alcohol- 
dependent 
patients 
n=345 
 
 
Alcohol-
dependent 
patients 
without  
co-occurring 
opioid 
dependence  
n=225 
 
Alcohol- 
dependent 
patients with 
co-occurring 
opioid 
dependence 
n=120 
 
Comparison between 
alcohol-dependent 
patients with and 
without co-occurring 
opioid dependence 
 
χ2/U, p value 
Lifetime suicide 
attempt;  
n (%)  
89 (25.8) 63 (28.0) 26 (21.7) 1.64, 0.20 
Violent suicide 
method; n (%) 
38 (11.0) 27 (12.0) 11 (9.0) 0.25, 0.62 
Gender: 
male/female  
(% males)  
284/97 (71.9) 
  
161/64 (71.6) 87/33 (72.5) 0.035,  0.85 
Age;  
mean ± SD  
40.2 ± 9.8 43.5 ± 9.9  34.2 ± 5.5 5856,  <0.001 
Severity of 
alcohol 
dependence 
(MAST); 
median, IQR 
29 (16-38) 34 (29-41) 12 (9-19) 2623,  <0.001 
Social support 
(MOSSSS); 
median, IQR 
64 (49-79) 60 (46-74) 74 (55-82) 9749,  <0.001 
Impulsivity 
(BIS);  
median, IQR 
69 (64-75) 72 (66-78) 65 (61-70) 7278,  <0.001 
Severe 
depression (BDI: 
29 or more); 
n (%) 
62 (18.1),  45 (20.2) 17 (14.3) 1,82,  0.18 
p< 0.05 were boldfaced 
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Table 2. Distribution of genotypes of GRIN2B rs2268115 polymorphism and analysis of the 
association between the analyzed polymorphism and completed suicide or suicide attempt 
 
 Completed suicide Suicide attempt in alcohol-dependent individuals 
Suicide 
victims 
n=503 
Controls 
n=449 
All alcohol- 
dependent 
patients 
n=340 
Alcohol-
dependent patients 
without  
co-occurring 
opioid dependence  
n=224 
Alcohol- 
dependent patients with 
co-occurring opioid 
dependence 
n=116 
Suicide 
attempt 
  Yes 
n=87 
No 
n=253 
Yes 
n=63 
No 
n= 161 
Yes 
n=24 
No 
n=92 
HWE p 0.647 0.558 0.454 0.634 0.402 0.382 0.889 0.703 
Genotypes (%) 
G/G 99 
(19.7) 
86 
(19.1) 
24 
(27.6) 
45 
(17.8) 
20 
(31.8) 
31 
(19.3) 
4  
(16.7) 
14  
(15.2) 
G/T 254 
(50.5) 
214 
(47.7) 
40 
(46.0) 
119 
(47.0) 
28 
(44.4) 
73 
(45.3) 
12 (50.0)  46  
(50.0) 
T/T 150 
(29.8) 
149 
(33.2) 
23 
(26.4) 
89 
(35.2) 
15 
(23.8) 
57 
(35.4) 
8  
(33.3) 
32  
(34.8) 
Allele (%) 
G  452 
(44.9) 
386 
(43.0) 
 88 
(50.6) 
209 
(41.3) 
68 
(54.0) 
135 
(42.0) 
20  
(41.7) 
74  
(40.2) 
T 554 
(55.1) 
512 
(57.0) 
86 
(49.4) 
297 
(58.7) 
58 
(46.0) 
187 
(58.0) 
28  
(58.3) 
110 
(59.8) 
Allelic 
comparison  
OR (CI), P 
 
1.08 (0.90; 1.30) 
0.405 
 
1.45 (1.03; 2.06) 
0.033 
 
1.62 (1.07; 2.46) 
0.021 
 
0.94 (0.49; 1.78) 
0.855 
Models of inheritance  
Recessive  
OR (CI) 
P, P fit 
GG vs GT/TT 
 
1.03 (0.75; 1.43) 
0.837, 0.267 
 
1.78(1.00; 3.11) 
0.056, 0.373 
 
1.75 (0.90; 3.41) 
0.089, 0.153 
 
1.11 (0.33; 3.76) 
0.862, 0.934 
 
Co-dominant  
OR (CI) 
P, P fit 
GG vs TG 
vs TT 
 
1.08 (0.90; 1.30) 
0.394,0.459 
 
1.43 (1.02; 2.01) 
0.038, 0.692 
 
1.57 (1.05; 2.34) 
0.027, 0.812 
 
1.06 (0.55; 2.05) 
0.853, 0.959 
 
Dominant  
OR (CI) 
P, P fit 
GT/GG vs TT 
 
1.17 (0.89; 1.54) 
0.264, 0.861 
 
1.51(0.88; 2.60) 
0.130, 0.142 
 
1.95 (1.01; 3.77) 
0.050, 0.298 
 
1.07 (0.41; 2.76) 
0.894, 0.890 
p< 0.05 were boldfaced  
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Table 3. Comparison between alcohol-dependent patients with and without history of lifetime suicide attempts  
Variables All alcohol-dependent patients 
n=345 
Alcohol-dependent patients without 
co-occurring opioid dependence  
n=225 
Alcohol-dependent patients 
with co-occurring opioid 
dependence 
n=120 
Lifetime suicide attempt  
 
Yes 
n=89 
No 
n=256 
χ2/U, 
p value 
Yes 
n=63 
No 
n=162 
χ2/U, 
 p value 
Yes 
n=26 
No 
n=94 
χ2/U,  
p value 
Gender: male/female  
(% males)  
62/27 
(69.7) 
186/70 
(72.7) 
0.75, 
0.39 
43/20 
(68.3) 
118/44 
(72.8) 
1.14,  
0.29 
19/7  
(73.1) 
68/26 
(72.3) 
0.23, 
0.88 
Age;  
mean ± SD 
39.2 ± 9.5 40.6  ± 10 41680, 
0.29 
41.3 ± 10 44.3 ± 10 17018, 
0.008 
34.2 ± 7 34.2 ± 5 4336, 
0.85 
Severity of alcohol dependence 
(MAST); median, IQR 
29 
(18-39) 
30  
(15-38) 
40618, 
0.22 
34  
(28-40) 
34  
(29-42) 
18768, 
0.33 
14  
(10-20) 
12  
(9-18) 
3796, 
0.16 
Social support (MOSSSS); 
median, IQR 
54  
(41-72) 
69  
(52-71) 
30128, 
<0.001 
51  
(37-69) 
63  
(49-76) 
14428, 
<0.001 
59  
(45-73) 
77  
(59-85) 
2860, 
<0.001 
Impulsivity (BIS);  
median, IQR 
73  
(66-80) 
68  
(63-73) 
31226, 
<0.001 
75.5  
(69-82) 
71  
(64-76) 
13466, 
<0.001 
66.5 
(63-70) 
65  
(61-69) 
3852, 
0.21 
Severe depression (BDI: 29 or 
more); n (%) 
35 
 (39.8) 
27  
(10.6) 
76.5, 
<0.001 
28  
(45.2) 
17  
(10.6) 
65.8,  
<0.001 
7  
(26.9) 
10  
(10.8) 
9.96, 
0.002 
p< 0.05 were boldfaced 
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Table 4. Logistic regression model of factors associated with a history of suicide attempts in 
alcohol-dependent patients 
 
All alcohol-dependent patients* 
Variable Odds Ratio (95%CI) p 
GRIN2B rs2268115 polymorphism  1.67 (1.14; 2.46) 0.008 
Impulsiveness (BIS) 1.03 (1.01; 1.05) 0.009 
Social support (MOSSSS) 0.98 (0.97; 0.99) <0.001 
Severe depression (BDI) 4.11 (2.61; 6.47) <0.001 
Age 0.98 (0.97;1.00) 0.61 
Alcohol-dependent patients without co-occurring opioid dependence** 
Variable Odds Ratio (95%CI) p 
GRIN2B rs2268115 polymorphism  2.01 (1.25; 3.24) 0.004 
Impulsiveness (BIS) 1.04 (1.01; 1.07) 0.009 
Social support (MOSSSS) 0.98 (0.97; 0.99) 0.021 
Severe depression (BDI) 4.79 (2.72; 8.47) <0.001 
Age 0.97 (0.95; 0.99) 0.026 
p< 0.05 were boldfaced 
* the overall model was statistically significant (χ2 = 100.9,df=5, p < 0.001) 
** the overall model was statistically significant  (χ2 = 89.5, df=5, p < 0.0001) 
 
 
 
 
